Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Beijing Yuewei Medical Technology

Request full access

Cardiac surgery interventional medical devices

ChinaFounded 2019Biotech & Life Sciences

About Beijing Yuewei Medical Technology

Beijing Yuewei Gene Technology Co., Ltd., also known as Microread Genetics, operates as a specialized firm in the molecular diagnostics sector, concentrating on the development and provision of multi-gene panel testing solutions. The company was established in December 2007 by Chen Chuguang, who currently serves as the chairman. Mr. Chen, holding a Master's degree in medical molecular biology from the Chinese Academy of Medical Sciences, transitioned from a research scientist role to entrepreneurship with the aim of translating scientific knowledge into practical, industrialized applications. Co-founder Guo Lihua, who also holds a Master's degree, serves as the General Manager.

The firm's core business revolves around a medium-throughput gene detection technology platform that combines PCR with capillary electrophoresis. This technical foundation enables the company to offer integrated solutions that encompass detection equipment, diagnostic reagents, and analysis software. The business model is structured to address the needs of two primary markets: forensic science and clinical medicine. In the forensic sector, Yuewei Gene provides a complete one-stop solution for public security DNA database construction and criminal case detection, covering everything from sample collection and preservation to analysis software. Their products in this area are utilized by public security bureaus across 28 provinces in China.

In the clinical diagnostics arena, the company is developing a product portfolio targeting major diseases related to oncology, genetic disorders, and cardiovascular conditions. A notable product is its microsatellite instability (MSI) gene detection kit, which was the first of its kind in China based on all mononucleotide loci. The firm has also secured registration for its GenReader 7010 gene analyzer. To expand its market reach in the clinical field, Yuewei Gene employs a direct sales force for academic promotion to hospitals and engages in strategic partnerships, including collaborations with companies like Thermo Fisher. The company has received multiple rounds of funding from prominent investors, including Sequoia China and RedHill Capital.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
22.0/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Oncology, Genetics and genomics, Health Diagnostics, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Apr 2025 $14M $55M Shaanxi Fund ↗
SERIES A✓Equity / VC Dec 2023 $14M $55M IDG Capital · South China Venture Capital · Yuanhui Capital · Innolink Fund ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Beijing Yuewei Medical Technology in its local ecosystem

Live from Dealroom

The Beijing Yuewei Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A5 investors entered at this stage

  • South China Venture Capital
  • Yuanhui Capital
  • Innolink Fund
  • Noyu Capital
  • Shaanxi Fund
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Beijing Yuewei Medical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Beijing Yuewei Medical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.